164 related articles for article (PubMed ID: 32098568)
1. Novel and potent inhibitors for dihydropteroate synthase of
Satuluri SH; Katari SK; Pasala C; Amineni U
J Recept Signal Transduct Res; 2020 Jun; 40(3):246-256. PubMed ID: 32098568
[TBL] [Abstract][Full Text] [Related]
2. In silico probing exercises, bioactive-conformational and dynamic simulations strategies for designing and promoting selective therapeutics against Helicobacter pylori strains.
Pasala C; Katari SK; Nalamolu RM; Bitla AR; Amineni U
J Mol Graph Model; 2019 Nov; 92():167-179. PubMed ID: 31376734
[TBL] [Abstract][Full Text] [Related]
3. Computational insights into factor affecting the potency of diaryl sulfone analogs as Escherichia coli dihydropteroate synthase inhibitors.
Das BK; Pv P; Chakraborty D
Comput Biol Chem; 2019 Feb; 78():37-52. PubMed ID: 30497019
[TBL] [Abstract][Full Text] [Related]
4. Validation of molecular docking programs for virtual screening against dihydropteroate synthase.
Hevener KE; Zhao W; Ball DM; Babaoglu K; Qi J; White SW; Lee RE
J Chem Inf Model; 2009 Feb; 49(2):444-60. PubMed ID: 19434845
[TBL] [Abstract][Full Text] [Related]
5. Crystal structures of Burkholderia cenocepacia dihydropteroate synthase in the apo-form and complexed with the product 7,8-dihydropteroate.
Morgan RE; Batot GO; Dement JM; Rao VA; Eadsforth TC; Hunter WN
BMC Struct Biol; 2011 May; 11():21. PubMed ID: 21554707
[TBL] [Abstract][Full Text] [Related]
6. 8-Mercaptoguanine Derivatives as Inhibitors of Dihydropteroate Synthase.
Dennis ML; Lee MD; Harjani JR; Ahmed M; DeBono AJ; Pitcher NP; Wang ZC; Chhabra S; Barlow N; Rahmani R; Cleary B; Dolezal O; Hattarki M; Aurelio L; Shonberg J; Graham B; Peat TS; Baell JB; Swarbrick JD
Chemistry; 2018 Feb; 24(8):1922-1930. PubMed ID: 29171692
[TBL] [Abstract][Full Text] [Related]
7. Inhibitory effect of natural compounds on Dihydropteroate synthase of
Khan M; Khan S; Bushara NZA; Ali R; Tabassum Z; Ishrat R; Marouf HA; Sherwani S; Mirza S; Haque S
J Biomol Struct Dyn; 2023; 41(23):13857-13872. PubMed ID: 37070201
[TBL] [Abstract][Full Text] [Related]
8. Crystal structure of Mycobacterium tuberculosis 7,8-dihydropteroate synthase in complex with pterin monophosphate: new insight into the enzymatic mechanism and sulfa-drug action.
Baca AM; Sirawaraporn R; Turley S; Sirawaraporn W; Hol WG
J Mol Biol; 2000 Oct; 302(5):1193-212. PubMed ID: 11007651
[TBL] [Abstract][Full Text] [Related]
9. Structure-based design of a potent and selective small peptide inhibitor of Mycobacterium tuberculosis 6-hydroxymethyl-7, 8-dihydropteroate synthase: a computer modelling approach.
Rao GS; Kumar M
Chem Biol Drug Des; 2008 Jun; 71(6):540-5. PubMed ID: 18482337
[TBL] [Abstract][Full Text] [Related]
10. Crystal structure of 7,8-dihydropteroate synthase from Bacillus anthracis: mechanism and novel inhibitor design.
Babaoglu K; Qi J; Lee RE; White SW
Structure; 2004 Sep; 12(9):1705-17. PubMed ID: 15341734
[TBL] [Abstract][Full Text] [Related]
11. Structural studies of pterin-based inhibitors of dihydropteroate synthase.
Hevener KE; Yun MK; Qi J; Kerr ID; Babaoglu K; Hurdle JG; Balakrishna K; White SW; Lee RE
J Med Chem; 2010 Jan; 53(1):166-77. PubMed ID: 19899766
[TBL] [Abstract][Full Text] [Related]
12. Molecular docking and simulation study for synthesis of alternative dapsone derivative as a newer antileprosy drug in multidrug therapy.
Swain SS; Paidesetty SK; Dehury B; Sahoo J; Vedithi SC; Mahapatra N; Hussain T; Padhy RN
J Cell Biochem; 2018 Dec; 119(12):9838-9852. PubMed ID: 30125973
[TBL] [Abstract][Full Text] [Related]
13. Exploring the catalytic mechanism of dihydropteroate synthase: elucidating the differences between the substrate and inhibitor.
Chotpatiwetchkul W; Boonyarattanakalin K; Gleeson D; Gleeson MP
Org Biomol Chem; 2017 Jul; 15(26):5593-5601. PubMed ID: 28639657
[TBL] [Abstract][Full Text] [Related]
14. Integration of core hopping, quantum-mechanics, molecular mechanics coupled binding-energy estimations and dynamic simulations for fragment-based novel therapeutic scaffolds against Helicobacter pylori strains.
Pasala C; Katari SK; Nalamolu RM; Aparna RB; Amineni U
Comput Biol Chem; 2019 Dec; 83():107126. PubMed ID: 31557645
[TBL] [Abstract][Full Text] [Related]
15. In-silico Designing, ADMET Analysis, Synthesis and Biological Evaluation of Novel Derivatives of Diosmin Against Urease Protein and Helicobacter pylori Bacterium.
Kataria R; Khatkar A
Curr Top Med Chem; 2019; 19(29):2658-2675. PubMed ID: 31724503
[TBL] [Abstract][Full Text] [Related]
16. New acrylamide-sulfisoxazole conjugates as dihydropteroate synthase inhibitors.
Nasr T; Bondock S; Ibrahim TM; Fayad W; Ibrahim AB; AbdelAziz NA; Sakr TM
Bioorg Med Chem; 2020 May; 28(9):115444. PubMed ID: 32220521
[TBL] [Abstract][Full Text] [Related]
17. Shape-based virtual screening, docking, and molecular dynamics simulations to identify Mtb-ASADH inhibitors.
Kumar R; Garg P; Bharatam PV
J Biomol Struct Dyn; 2015; 33(5):1082-93. PubMed ID: 24875451
[TBL] [Abstract][Full Text] [Related]
18. In silico approach towards identification of potential inhibitors of Helicobacter pylori DapE.
Mandal RS; Das S
J Biomol Struct Dyn; 2015; 33(7):1460-73. PubMed ID: 25204745
[TBL] [Abstract][Full Text] [Related]
19. Para-(benzoyl)-phenylalanine as a potential inhibitor against LpxC of Leptospira spp.: homology modeling, docking, and molecular dynamics study.
Pradhan D; Priyadarshini V; Munikumar M; Swargam S; Umamaheswari A; Bitla A
J Biomol Struct Dyn; 2014; 32(2):171-85. PubMed ID: 23383626
[TBL] [Abstract][Full Text] [Related]
20. A rapid assay for dihydropteroate synthase activity suitable for identification of inhibitors.
Fernley RT; Iliades P; Macreadie I
Anal Biochem; 2007 Jan; 360(2):227-34. PubMed ID: 17134675
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]